Researchers at the University of Adelaide are undertaking ground-breaking research for a potential new treatment for prostate cancer.
Prostate cancer is the most common cancer found in Australian men – around 20,000 new cases are diagnosed each year – and it's the second most common cause of cancer-related death.
Most research in prostate cancer treatment has focused on drugs to block the actions of male hormones in the cancer cells, but patients often become resistant to these treatments.
The University of Adelaide's research is to find a new way of destroying the resistant cancer cells and through this researchers hope to improve survival rates.
Currently, treatment for men with a resistant disease can only extend their lives for a short period, however this new breakthrough may provide a promising solution.
"This global project is a completely new direction for prostate cancer research, and we are very excited to be a major part of it," said Professor Wayne Tilley, head of the University of Adelaide's Dame Roma Mitchell Cancer Research Laboratories.
As Men's Health Week is coming up from June 10-16, there's no time like the present for men to go along for a check-up and any following treatment that could be required.
The hub of this research is happening at the Adelaide Prostate Cancer Research Centre, in the University's Dame Roma Mitchell Cancer Research Laboratories. It's the hub for what is an international collective involving parties from the US, UK, Belgium and Singapore as well as Australia, who have all decided to work together to find a new approach in the treatment of prostate cancer.
This new research is being funded from a $600,000 Cancer Australia grant and a $300,000 grant from the Ray and Shirl Norman Cancer Research Trust in South Australia.
Remember regularly monitoring your heath and investing in a good private health insurance policy are two ways in which you can help to look after your well being and quality of life.